Chronic kidney disease: Obesity in children with end-stage renal disease

Rafael T Krmar1, Peter Bárány

  • 1Department of Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institute, B 57 Huddinge, Karolinska University Hospital, SE-141 86 Stockholm, Sweden.

Insights

Children with end-stage renal disease, especially those who received a kidney transplant, often experience overweight or obesity. Infants with this condition are more likely to be underweight, indicating a need for tailored interventions.

Area of Science:

  • Pediatric Nephrology
  • Childhood Obesity
  • Renal Disease Management

Background:

  • End-stage renal disease (ESRD) significantly impacts pediatric health.
  • Nutritional status in children with ESRD requires careful monitoring.
  • Overweight, obesity, and underweight are critical concerns in this vulnerable population.

Purpose of the Study:

  • To determine the prevalence of overweight and obesity in children with ESRD.
  • To identify specific nutritional challenges in different age groups within the pediatric ESRD population.
  • To underscore the necessity for targeted nutritional interventions in pediatric ESRD.

Main Methods:

  • Retrospective analysis of anthropometric data in pediatric patients with ESRD.
  • Stratification of nutritional status by age group and renal replacement therapy status.
  • Comparison of prevalence rates with established pediatric growth standards.

Main Results:

  • A high prevalence of overweight or obesity was observed in children with ESRD.
  • Renal transplant recipients showed a particularly high incidence of overweight/obesity.
  • Underweight was more common in infants compared to older children with ESRD.

Conclusions:

  • Children with ESRD exhibit significant nutritional abnormalities, including high rates of overweight and obesity.
  • Infants with ESRD face a distinct risk of underweight.
  • Urgent evaluation and implementation of nutritional interventions are crucial for improving outcomes in pediatric ESRD patients.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
332
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
5.0K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
850